From Early Development Into Clinic – De-Risking A Bioconjugate's Journey

The journey of a novel bioconjugate into clinic is complex and uncertain. In this webinar, we explore the particular challenges when moving a bioconjugate candidate from early development into clinic. Our experts share key considerations for de-risking this journey, from navigating the diverse conjugation technology landscape to designing a robust and scalable process through development. Several customer case studies illustrate how Lonza’s expertise and integrated solutions have helped drug developers to bring their innovative therapeutics to life.

Key objectives of the webinar are:

• How Lonza’s toolbox solution can help you navigate the diverse conjugation technology landscape
• The importance of a thorough process development to improve robustness and scalability
• The benefits of an integrated offering to minimize interfaces, reduce complexity and meet tight timelines